Vanda Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference

WASHINGTON, June 2, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the Jefferies Global Healthcare Conference in New York City on Thursday, June 4, 2015 at 12:30 p.m. Eastern Time.

The presentation at the Jefferies Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Senior Vice President and Chief Financial Officer

Vanda Pharmaceuticals Inc.

SOURCE Vanda Pharmaceuticals Inc.

more press release views with